Amplification of the COX/TXS/TP receptor pathway enhances uridine diphosphate-induced contraction by advanced glycation end products in rat carotid arteries

  • Takayuki MatsumotoEmail author
  • Mihoka Kojima
  • Keisuke Takayanagi
  • Tomoki Katome
  • Kumiko Taguchi
  • Tsuneo KobayashiEmail author
Molecular and cellular mechanisms of disease
Part of the following topical collections:
  1. Molecular and cellular mechanisms of disease


Advanced glycation end products (AGEs) play a pivotal role in vascular functions under various pathophysiological conditions. Although uridine diphosphate (UDP) is an important extracellular nucleotide, the relationship between AGEs and UDP regarding their effect on vascular functions remains unclear. Therefore, we investigated the effects of AGE-bovine serum albumin (AGE-BSA) on UDP-mediated responses in rat thoracic aorta and carotid arteries. In rat thoracic aorta, UDP-induced relaxation was observed and this relaxation was similar between control (1.0 v/v% PBS) and AGE-BSA-treated (0.1 mg/mL for 60 min) groups. In contrast, contraction but not relaxation was obtained following UDP application to carotid arteries with and without endothelia; contraction was greater in the AGE-BSA-treated group than in the control group. The difference in UDP-induced contraction between the two groups was not abolished by the use of a nitric oxide synthase (NOS) inhibitor, whereas it was abolished by the use of cyclooxygenase (COX), thromboxane synthase (TXS), and thromboxane-prostanoid (TP) receptor antagonist. Further, the difference in UDP-induced contraction was not abolished by the use of a cPLA2 inhibitor, whereas it was abolished by the use of an iPLA2 inhibitor. UDP increased TXA2 release in both groups, and its level was similar in both groups. Moreover, the release of PGE2, PGF, and PGI2 was similar among the groups. Under NOS inhibition, TP receptor agonist–induced contraction increased in the AGE-BSA-treated group (vs. control group). In conclusion, the increase in UDP-induced carotid arterial contraction by AGE-BSA can be attributed to an increase in the COX/TXS/TP receptor pathway, particularly, TP receptor signaling.


Advanced glycation end products Carotid arteries Contraction Thromboxane-prostanoid receptor Uridine diphosphate Vascular smooth muscle 



We would like to thank Yuri Asano, Akari Ishibiki, Saya Imamura, Myu Kozakai, Kana Saegusa, Kanako Takimoto, Takeru Toda, Yuka Hayashida, Taiga Yoshida, Marina Ito, Yurika Ezaki, Amane Kurakata, Yuzuki Sato, Tamayo Hashimoto, Yurina Mae, and Hiyori Yokoyama for their excellent technical assistance. We also thank Enago ( for the English language review.

Author contributions

T.M. and T.K. conceived and designed the research; T.M., M.K., K.T., and T.K. performed the experiments; T.M., M.K., K.T., T.K, and K.T. analyzed the data; T.M., M.K., K.T., T.K., K.T., and T.K. interpreted the results of experiments; T.M. prepared the figures; T.M. drafted the manuscript; T.M. and T.K. edited and revised the manuscript; and T.M., M.K., K.T., T.K., K.T., and T.K. approved the final version of the manuscript.

Funding information

This work was supported in part by grants JSPS KAKENHI grant numbers JP18K06861 (to Takayuki Matsumoto), JP17K08318 (to Kumiko Taguchi), and JP18K06974 (to Tsuneo Kobayashi).

Compliance with ethical standards

All animal studies were conducted according to the Guiding Principles for the Care and Use of Laboratory Animals from the Committee for the Care and Use of Laboratory Animals of Hoshi University (Tokyo, Japan) (permission code: 29-086).

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Abbas ZSB, Latif ML, Dovlatova N, Fox SC, Heptinstall S, Dunn WR, Ralevic V (2018) UDP-sugars activate P2Y14 receptors to mediate vasoconstriction of the porcine coronary artery. Vasc Pharmacol 103-105:36–46Google Scholar
  2. 2.
    Ackermann EJ, Conde-Frieboes K, Dennis EA (1995) Inhibition of macrophage Ca2+-independent phospholipase A2 by bromoenol lactone and trifluoromethyl ketones. J Biol Chem 270:445–450PubMedGoogle Scholar
  3. 3.
    Alsaquati M, Latif ML, Chan SL, Ralevic V (2014) Novel vasocontractile role of the P2Y14 receptor: characterization of its signalling in porcine isolated pancreatic arteries. Br J Pharmacol 17:701–713Google Scholar
  4. 4.
    Balsinde J, Dennis EA (1996) Distinct roles in signal transduction for each of the phospholipase A2 enzymes present in P388D1 macrophages. J Biol Chem 271:6758–6765PubMedGoogle Scholar
  5. 5.
    Bar I, Guns PJ, Metallo J, Cammarata D, Wilkin F, Boeynams JM, Bult H, Robaye B (2008) Knockout mice reveal a role for P2Y6 receptor in macrophages, endothelial cells, and vascular smooth muscle cells. Mol Pharmacol 74:777–784PubMedGoogle Scholar
  6. 6.
    Bodiga VL, Eda SR, Bodiga S (2014) Advanced glycation end products: role in pathology of diabetic cardiomyopathy. Heart Fail Rev 19:49–63PubMedGoogle Scholar
  7. 7.
    Burke JE, Dennis EA (2009) Phospholipase A2 biochemistry. Cardiovasc Drugs Ther 23:49–59PubMedGoogle Scholar
  8. 8.
    Burnstock G (2017) Purinergic signaling in the cardiovascular system. Circ Res 120:207–228PubMedGoogle Scholar
  9. 9.
    Cane A, Breton M, Bereziat G, Colard O (1997) Phospholipase A2-dependent and-independent pathways of arachidonate release from vascular smooth muscle cells. Biochem Pharmacol 53:327–337PubMedGoogle Scholar
  10. 10.
    Ciana P, Fumagalli M, Trincavelli ML, Verderio C, Rosa P, Lecca D, Ferrario S, Parravicini C, Capra V, Gelosa P, Guerrini U, Belcredito S, Cimino M, Sironi L, Tremoli E, Rovati GE, Martini C, Abbracchio MP (2006) The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J 25:4615–4627PubMedPubMedCentralGoogle Scholar
  11. 11.
    Daniels SB, Cooney E, Sofia MJ, Chakravarty PK, Katzenellenbogen JA (1983) Haloenol lactones. Potent enzyme-activated irreversible inhibitors for alpha-chymotrypsin. J Biol Chem 258:15046–15053PubMedGoogle Scholar
  12. 12.
    Erlinge D, Burnstock G (2008) P2 receptors in cardiovascular regulation and disease. Purinergic Signal 4:1–20PubMedGoogle Scholar
  13. 13.
    Fishman SL, Sonmez H, Basman C, Singh V, Poretsky L (2018) The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review. Mol Med 24:59PubMedPubMedCentralGoogle Scholar
  14. 14.
    Fuentes L, Perez R, Nieto ML, Balsinde J, Balboa MA (2003) Bromoenol lactone promotes cell death by a mechanism involving phosphatidate phosphohydrolase-1 rather than calcium-independent phospholipase A2. J Biol Chem 278:44683–44690PubMedGoogle Scholar
  15. 15.
    Gallicchio MA, Bach LA (2010) Advanced glycation end products inhibit Na+ K+ ATPase in proximal tubule epithelial cells: role of cytosolic phospholipase A2alpha and phosphatidylinositol 4-phosphate 5-kinase gamma. Biochim Biophys Acta 1803:919–930PubMedGoogle Scholar
  16. 16.
    Guns PJ, Korda A, Crauwels HM, Van Assche T, Robaye B, Boeynaems JM, Bult H (2005) Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta. Br J Pharmacol 146:288–295PubMedPubMedCentralGoogle Scholar
  17. 17.
    Guo Z, Su W, Ma Z, Smith GM, Gong MC (2003) Ca2+-independent phospholipase A2 is required for agonist-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 278:1856–1863PubMedGoogle Scholar
  18. 18.
    Haanes KA, Spray S, Syberg S, Jorgensen NR, Robaye B, Boeynaems JM, Edvinsson L (2016) New insights on pyrimidine signalling within the arterial vasculature-different roles for P2Y2 and P2Y6 receptors in large and small coronary arteries of the mouse. J Mol Cell Cardiol 93:1–11PubMedGoogle Scholar
  19. 19.
    Hou M, Harden TK, Kuhn CM, Baldetorp P, Lazarowski E, Pendergast W, Moller S, Edvinsson L, Erlinge D (2002) UDP acts as a growth for vascular smooth muscle cells by activation of P2Y(6) receptors. Am J Physiol Heart Circ Physiol 282:H784–H792PubMedGoogle Scholar
  20. 20.
    Hurt-Camejo E, Andersen S, Standal R, Rosengren B, Sartipy P, Stadberg E, Johansen B (1997) Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Arterioscler Thromb Vasc Biol 17:300–309PubMedGoogle Scholar
  21. 21.
    Ishida K, Matsumoto T, Taguchi K, Kamata K, Kobayashi T (2011) Mechanisms underlying altered extracellular nucleotide-induced contractions in mesenteric arteries from rats in later-stage type 2 diabetes: effect of ANG II type 1 receptor antagonism. Am J Physiol Heart Circ Physiol 301:H1850–H1861PubMedGoogle Scholar
  22. 22.
    Ishida K, Taguchi K, Matsumoto T, Kobayashi T (2014) Activated platelets from diabetic rats cause endothelial dysfunction by decreasing Akt/endothelial NO synthase signaling pathway. PLoS One 97:e102310Google Scholar
  23. 23.
    Jakus V, Rietbrock N (2004) Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res 53:131–114PubMedGoogle Scholar
  24. 24.
    Ji X, Nishihashi T, Trandafir CC, Wang A, Shimizu Y, Kurahashi K (2007) Pharmacological nature of nicotine-induced contraction in the rat basilar artery: involvement of arachidonic acid metabolites. Eur J Pharmacol 577:109–114PubMedGoogle Scholar
  25. 25.
    Kauffenstein G, Tamareille S, Prunier F, Roy C, Ayer A, Toutain B, Billaud M, Isakson BE, Grimaud L, Loufrani L, Rousseau P, Abraham P, Procaccio V, Monyer H, de Wit C, Boeynaems JM, Robaye B, Kwak BR, Henrion D (2016) Central role of P2Y6 UDP receptor in arteriolar myogenic tone. Arterioscler Thromb Vasc Biol 36:1598–1606PubMedPubMedCentralGoogle Scholar
  26. 26.
    Kobayashi S, Matsumoto T, Ando M, Iguchi M, Watanabe S, Taguchi K, Kobayashi T (2018) UDP-induced relaxation is enhanced in aorta from female obese Otsuka Long-Evans Tokushima Fatty rats. Purinergic Signal 14:91–96PubMedGoogle Scholar
  27. 27.
    Lan KC, Chiu CY, Kao CW, Huang KH, Wang CC, Huang KT, Tsai KS, Sheu ML, Liu SH (2015) Advanced glycation end-products induce apoptosis in pancreatic islet endothelial cells via NF-kB-activated cyclooxygenase-2/prostaglandin E2 up-regulation. PLoS One 10:e0124418PubMedPubMedCentralGoogle Scholar
  28. 28.
    Langley D, Pearce B (1998) Pyrimidine nucleotide-stimulated thromboxane A2 release from cultured glia. Cell Mol Neurobiol 18:477–486PubMedGoogle Scholar
  29. 29.
    Li R, Tan B, Yan Y, Ma X, Zhang N, Zhang Z, Liu M, Qian M, Du B (2014) Extracellular UDP and P2Y6 function as a danger signal to protect mice from vesicular stomatitis virus infection through an increase in IFN-β production. J Immunol 193:4515–4512PubMedGoogle Scholar
  30. 30.
    Lin WW, Lee YT (1996) Pyrimidinoceptor-mediated activation of phospholipase C and phospholipase A2 in RAW 264.7 macrophages. Br J Pharmacol 119:261–268PubMedPubMedCentralGoogle Scholar
  31. 31.
    Matsumoto T, Ishida K, Nakayama N, Taguchi K, Kobayashi T, Kamata K (2010) Mechanisms underlying the losartan treatment-induced improvement in the endothelial dysfunction seen in mesenteric arteries from type 2 diabetic rats. Pharmacol Res 62:271–281PubMedGoogle Scholar
  32. 32.
    Matsumoto T, Tostes RC, Webb RC (2011) Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol 301:H409–H417PubMedPubMedCentralGoogle Scholar
  33. 33.
    Matsumoto T, Watanabe S, Kawamura R, Taguchi K, Kobayashi T (2014) Enhanced uridine adenosine tetraphosphate-induced contraction in renal artery from type 2 diabetic Goto-Kakizaki rats due to activated cyclooxygenase/thromboxane receptor axis. Pflugers Arch 466:331–342PubMedGoogle Scholar
  34. 34.
    Matsumoto T, Goulopoulou S, Taguchi K, Tostes RC, Kobayashi T (2015) Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. Br J Pharmacol 172:3980–4001PubMedPubMedCentralGoogle Scholar
  35. 35.
    Matsumoto T, Kobayashi S, Ando M, Iguchi M, Takayanagi K, Kojima M, Taguchi K, Kobayashi T (2017) Alteration of vascular responsiveness to uridine adenosine tetraphosphate in aortas isolated from male diabetic Otsuka Long-Evans Tokushima Fatty rats: the involvement of prostanoids. Int J Mol Sci 18:E2378PubMedGoogle Scholar
  36. 36.
    Mombouli JV, Vanhoutte PM (1993) Purinergic endothelium-dependent and -independent contractions in rat aorta. Hypertension 22:577–583PubMedGoogle Scholar
  37. 37.
    Mukohda M, Morita T, Okada M, Hara Y, Yamawaki H (2012) Long-term methylglyoxal treatment impairs smooth muscle contractility in organ-cultured rat mesenteric artery. Pharmacol Res 65:91–99PubMedGoogle Scholar
  38. 38.
    Murakami M, Kudo I (2002) Phospholipase A2. J Biochem 13:285–292Google Scholar
  39. 39.
    Nah SS, Choi IY, Lee CK, Oh JS, Kim YG, Moon HB, Yoo B (2008) Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteroarthritic chondrocytes. Rheumatology 47:425–431PubMedGoogle Scholar
  40. 40.
    Nishimura A, Sunggip C, Tozaki-Saitoh H, Shimauchi T, Numaga-Tomita T, Hirano K, Ide T, Boeynaems JM, Kurose H, Tsuda M, Robaye B, Inoue K, Nishida M (2016) Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension. Sci Signal 9:ra7PubMedGoogle Scholar
  41. 41.
    Nishimura A, Sunggip C, Oda S, Numaga-Tomita T, Tsuda M, Nishida M (2017) Purinergic P2Y receptors: molecular diversity and implications for treatment of cardiovascular diseases. Pharmacol Ther 180:113–128PubMedGoogle Scholar
  42. 42.
    Nowotny K, Schroter D, Schreiner M, Grune T (2018) Dietary advanced glycation end products and their relevance for human health. Ageing Res Rev 47:55–66PubMedGoogle Scholar
  43. 43.
    Park KM, Trucillo M, Serban N, Cohen RA, Bolotina VM (2008) Role of iPLA2 and store-operated channels in agonist-induced Ca2+ influx and constriction in cerebral, mesenteric, and carotid arteries. Am J Physiol Heart Circ Physiol 294:H1183–H1187PubMedGoogle Scholar
  44. 44.
    Passaglia P, Gonzaga NA, Tirapelli DP, Tirapelli LF, Tirapelli CR (2014) Pharmacological characterization of the mechanisms underlying the relaxant effect of adrenomedullin in the rat carotid artery. J Pharm Pharmacol 66:1734–1746PubMedGoogle Scholar
  45. 45.
    Rubino A, Ziabary L, Burnstock G (1999) Regulation of vascular tone by UTP and UDP in isolated rat intrapulmonary arteries. Eur J Pharmacol 370:139–143PubMedGoogle Scholar
  46. 46.
    Soro-Paavonen A, Zhang WZ, Venardos K, Coughlan MT, Harris E, Tong DC, Brasacchio D, Paavonen K, Chin-Dusting J, Cooper ME, Kaye D, Thomas MC, Forbes JM (2010) Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase. J Hypertens 28:780–788PubMedGoogle Scholar
  47. 47.
    Stachon P, Peikert A, Michel NA, Hergeth S, Marchini T, Wolf D, Dufner B, Hoppe N, Ayata CK, Grimm M, Cicko S, Schulte L, Reinohl J, von zur Muhlen C, Bode C, Idzko M, Zirlik A (2014) P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 34:2237–2245PubMedGoogle Scholar
  48. 48.
    Su J, Lucchesi PA, Gonzalez-Villalobs RA, Palen DI, Rezk BM, Suzuki Y, Boulares HA, Matrougui K (2008) Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice. Arterioscler Thromb Vasc Biol 28:1432–1438PubMedPubMedCentralGoogle Scholar
  49. 49.
    Sunggip C, Nishimura A, Shimoda K, Numaga-Tomita T, Tsuda M, Nishida M (2017) Purinergic P2Y6 receptors: a new therapeutic target of age-dependent hypertension. Pharmacol Res 120:51–59PubMedGoogle Scholar
  50. 50.
    Tagashira H, Matsumoto T, Taguchi K, Zhang C, Han F, Ishida K, Nemoto S, Kobayashi T, Fukunaga K (2013) Vascular endothelial σ1-receptor stimulation with SA4503 rescues aortic relaxation via Akt/eNOS signaling in ovariectomized rats with aortic banding. Circ J 77:2831–2840PubMedGoogle Scholar
  51. 51.
    van Tienhoven M, Atkins J, Li Y, Glynn P (2002) Human neuropathy target esterase catalyzes hydrolysis of membrane lipids. J Biol Chem 277:20942–20948PubMedGoogle Scholar
  52. 52.
    Watanabe S, Matsumoto T, Oda M, Yamada K, Takagi J, Taguchi K, Kobayashi T (2016) Insulin augments serotonin-induced contraction via activation of the IR/PI3K/PDK pathway in the rat carotid artery. Pflugers Arch 468:667–677PubMedGoogle Scholar
  53. 53.
    Watanabe S, Matsumoto T, Ando M, Adachi T, Kobayashi S, Iguchi M, Takeuchi M, Taguchi K, Kobayashi T (2016) Multiple activation mechanisms of serotonin-mediated contraction in the carotid arteries obtained from spontaneously hypertensive rats. Pflugers Arch 468:1271–1282PubMedGoogle Scholar
  54. 54.
    Wong RK, Pettiti AI, Quinn PA, Jennings SC, Davies JE, Ng LL (2003) Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic acid. Circulation 108:1858–1864PubMedGoogle Scholar
  55. 55.
    Wong MS, Man RY, Vanhoutte PM (2010) Calcium-independent phospholipase A(2) plays a key role in the endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 298:H1260–H1266PubMedGoogle Scholar
  56. 56.
    Yamawaki H, Saito K, Okada M, Hara Y (2008) Methylglyoxal mediates vascular inflammation via JNK and p38 in human endothelial cells. Am J Physiol Heart Circ Physiol 295:C1510–C1517Google Scholar
  57. 57.
    Yang R, Zhu Y, Wang Y, Ma W, Han X, Wang X, Liu N (2019) HIF-1a/PDK4/autophagy pathway protects against advanced glycation end-products induced vascular smooth muscle cell calcification. Biochem Biophys Res Commun 517:470–476PubMedGoogle Scholar
  58. 58.
    Yuan T, Yang T, Chen H, Fu D, Hu Y, Wang J, Yuan Q, Yu H, Xu W, Xie X (2019) New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol 20:247–260PubMedGoogle Scholar
  59. 59.
    Zhao LM, Su XL, Wang Y, Li GR, Deng XL (2013) KCa3.1 channels mediate the increase of cell migration and proliferation by advanced glycation endproducts in cultured rat vascular smooth muscle cells. Lab Investig 93:159–167PubMedGoogle Scholar
  60. 60.
    Zhou Z, Sun C, Tilley SL, Mustafa SJ (2015) Mechanisms underlying uridine adenosine tetraphosphate-induced vascular contraction in mouse aorta: role of thromboxane and purinergic receptors. Vasc Pharmacol 73:78–85Google Scholar
  61. 61.
    Zhou Z, Matsumoto T, Jankowski V, Pernow J, Mustafa SJ, Duncker DJ, Merkus D (2019) Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: an update. Pharmacol Res 141:32–45PubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Physiology and Morphology, Institute of Medicinal ChemistryHoshi UniversityTokyoJapan

Personalised recommendations